Fabio Russomano

9PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersObstetrics and gynaecologyLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 30, 2026
Cost-utility of screening with liquid cytology or p16/Ki67 dual stain in women identified in cervical cancer triage with non 16/18 HR-HPV.

Isandra Meirelles, Marcia Pinto, Fabio Russomano

|Mar 27, 2026
Safety and Reproductive Outcomes of Minimally Invasive Nerve-Sparing Surgery for Deep Endometriosis in Infertile Women: A One-Year Follow-Up Study.

Bruna Rafaela Oliveira, Claudio Peixoto Crispi, Fabio Bastos Russomano

|Oct 02, 2023
Frequency of post-treatment disease after excisional procedure in stage IA1 squamous cervical carcinoma - a case series.

Pedro Abreu Azzi, Fábio Bastos Russomano, Cecilia Vianna de Andrade

|Aug 30, 2023
Cervical Intraepithelial Neoplasia grade 2 biopsy: Do p16INK4a and Ki-67 biomarkers contribute to the decision to treat? A cross-sectional study.

Amanda Leal Ferreira, Nasle Domingues Dibe, Bruna Rodrigues de Paiva

|Nov 18, 2022
Conventional cytologic diagnosis of human papillomavirus-induced anal intraepithelial neoplasia: The experience of a referral center in Rio de Janeiro, Brazil.

Lêda Pereira de Barcellos, José Ricardo Hildebrandt Coutinho, Andrea Cytryn

Pageof 2